Copyright
©The Author(s) 2022.
World J Cardiol. Sep 26, 2022; 14(9): 483-495
Published online Sep 26, 2022. doi: 10.4330/wjc.v14.i9.483
Published online Sep 26, 2022. doi: 10.4330/wjc.v14.i9.483
Figure 2 Association of electrocardiographic indices with cardiac magnetic resonance fibrosis in different clinical settings.
A: Association of Fragmented QRS (fQRS) with myocardial fibrosis in hypertrophic cardiomyopathy patients (Adapted from Dohy Z et al[13], 2020-permission is not required for this type of reuse); B: Association of Q wave with fibrosis in hypertrophic cardiomyopathy patients (adapted from Grall S et al[15], 2014-permission is not required for this type of reuse); C: Association of fQRS with fibrosis in myocarditis patients (adapted from Ferrero P et al[33], 2020-permission is not required for this type of reuse); D: Association of QRS voltage, QRS duration and QTc with fibrosis in the general population (adapted from Inoue YY et al[35], 2017-with permission from the Radiological Society of North America); E: Association of low QRS voltages with fibrosis in arrhythmogenic cardiomyopathy patients (adapted from De Lazzari M et al[37], 2018- permission is not required for this type of reuse).
- Citation: Bazoukis G, Garcia-Zamora S, Çinier G, Lee S, Elvin Gul E, Álvarez-García J, Miana G, Hayıroğlu Mİ, Tse G, Liu T, Baranchuk A. Association of electrocardiographic markers with myocardial fibrosis as assessed by cardiac magnetic resonance in different clinical settings. World J Cardiol 2022; 14(9): 483-495
- URL: https://www.wjgnet.com/1949-8462/full/v14/i9/483.htm
- DOI: https://dx.doi.org/10.4330/wjc.v14.i9.483